Bioprogress Future2

mknight,
I'd love a takeover at 150...provided it was the opening salvo. And therein lies the rub. If we're in talks with more than one top 10 pharma, will the others stand by why one takes the prize on the cheap? Methinks not.
And BTW, for everyone that thinks that because RT said discussions were happening with "a number of top 10 pharmas" that means more than one, could I remind them that one is a number, as is zero. I'm a lawyer and was corrected on this during my articles..."there is a number of reasons why I object blah blah because "a number" is singular while the number itslef could be anything. Borin point to make but RT was a lawyer too so bear it in mind.